A £3.2 million plan to expand one of the UK's main haematology centres is to get under way next month, it has been announced.
The expansion at the Queen Elizabeth Hospital, Birmingham, is backed by a locally-based charity, Cure Leukaemia, which has promised to raise £1 million towards it.
It is set to double the size of the existing Centre for Clinical Haematology, allowing more space for patient care and research.
Professor Charlie Craddock, who helped found the charity, said: ‘Once established, the Centre’s capacity for research nurse positions, clinical trials and patients treated will be doubled. Over 100 jobs will be created - further enhancing Birmingham’s reputation for clinical excellence in the life science sector.
‘Patient experience will be transformed by amalgamating all haematology and blood cancer services into a single space, from out-patient services to clinical trials.
‘These are just some of the benefits that the Centre’s development will enable. Not only will the Centre immediately increase the number of lives saved but also hasten global progress towards establishing effective treatments for all blood cancers within our lifetime.’
One of the architects of the expansion is a patient at the centre, treated for angioimmunoblastic T-cell lymphoma.
The architect Igor Kolodotschko said: ‘The clinics I attended at the Centre were always so busy and you could tell there were just too many patients for the staff to cope with and not enough space to comfortably house them.
‘I am sure this vital and transformational expansion of the Centre will ensure these pressures are placed firmly in the past and more and more patients are able to access the life-saving treatments I was lucky enough to benefit from.’
Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.